Fundraising FoxExeVir Bio
Ghent, BE · 6 known investors
Find your way into ExeVir Bio
ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations. The company operates as a clinical-stage biotech firm leveraging a modular antibody platform to accelerate drug development.
Founders & leadership
Investors · 6
V-Bio Ventures✓ confirmed by ExeVir BioGhent · $270K – $2.2M
How we know: the company's own site · Not right? Tell us
Sambrinvest✓ confirmed by ExeVir BioCharleroi
How we know: the company's own site · Not right? Tell us
Frequently asked questions
- What does ExeVir Bio do?
- ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations. The company operates as a clinical-stage biotech firm leveraging a modular antibody platform to accelerate drug development.
- Who founded ExeVir Bio?
- ExeVir Bio was founded by Xavier Saelens, Nico Callewaert.
- Who are ExeVir Bio's investors?
- ExeVir Bio's investors include V-Bio Ventures, Sambrinvest, UCB Ventures, VIB, Fund+, VIVES Partners.
- Where is ExeVir Bio headquartered?
- ExeVir Bio is headquartered in Ghent, BE.